News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thompson Rahsaan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2023 |
4
| Thompson Rahsaan (Chief Legal Officer) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 245,000 options to buy
@ $2.13, valued at
$521.9k
|
|
| 10/12/2022 |
4
| Thompson Rahsaan (Chief Legal Officer) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 715,000 options to buy
@ $6.91, valued at
$4.9M
|
|
| 10/03/2022 |
3
| Thompson Rahsaan (Chief Legal Officer) has filed a Form 3 on Lyell Immunopharma, Inc. |
| 04/20/2022 |
4
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,240 shares
@ $0
Granted 115,440 options to buy
@ $5.46, valued at
$630.3k
|
|
| 11/19/2021 |
4
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 25,500 shares
@ $0 |
|
| 03/10/2021 |
4
| Thompson Rahsaan (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 60,000 options to buy
@ $13.87, valued at
$832.2k
|
|
| 05/15/2020 |
4
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 85,000 options to buy
@ $6.4, valued at
$544k
|
|
| 04/14/2020 |
3
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 3 on Gritstone Oncology, Inc. |
| 09/20/2019 |
3
| Thompson Rahsaan (General Counsel) has filed a Form 3 on OPIANT PHARMACEUTICALS, INC. |
|
|